Desonide Patent Expiration
Desonide is Used for treating mild to moderate atopic dermatitis in patients 3 months of age and older. It was first introduced by Padagis Us Llc
Desonide Patents
Given below is the list of patents protecting Desonide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Desonate | US6387383 | Topical low-viscosity gel composition |
Aug 03, 2020
(Expired) | Leo Pharma As |
| Verdeso | US6730288 | Mousse composition |
Sep 08, 2019
(Expired) | Almirall |
| Verdeso | US7029659 | Mousse composition |
Sep 08, 2019
(Expired) | Almirall |
| Verdeso | US8460641 | Microemulsion process and composition | Aug 13, 2027 | Almirall |
| Verdeso | US8962000 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Almirall |
| Verdeso | US9492384 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Almirall |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desonide's patents.
Latest Legal Activities on Desonide's Patents
Given below is the list recent legal activities going on the following patents of Desonide.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Apr, 2024 | US9492384 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Apr, 2020 | US9492384 |
| Patent Issue Date Used in PTA Calculation | 15 Nov, 2016 | US9492384 |
| Recordation of Patent Grant Mailed | 15 Nov, 2016 | US9492384 |
| Email Notification | 27 Oct, 2016 | US9492384 |
| Issue Notification Mailed | 26 Oct, 2016 | US9492384 |
| Dispatch to FDC | 17 Oct, 2016 | US9492384 |
| Application Is Considered Ready for Issue | 14 Oct, 2016 | US9492384 |
| Issue Fee Payment Received | 13 Oct, 2016 | US9492384 |
| Issue Fee Payment Verified | 13 Oct, 2016 | US9492384 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Desonide Generics
Several generic applications have been filed for Desonide. The first generic version for Desonide was by Galderma Laboratories Lp and was approved on Jun 15, 1988. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Dec 8, 2022.
Given below is the list of companies who have filed for Desonide generic.
1. FOUGERA PHARMS
Fougera Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Fougera Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Mar 19, 2002 |
2. TARO
Taro Pharmaceutical Industries Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Oct 31, 2014 |
3. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Discontinued | TOPICAL | N/A | Mar 27, 2017 |
4. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Sep 28, 1992 |
5. CADILA
Cadila Healthcare Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cadila.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Nov 20, 2019 |
6. ENCUBE ETHICALS
Encube Ethicals Pvt Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Encube Ethicals.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Prescription | TOPICAL | AB | Jan 30, 2019 |
7. CINTEX SVCS
Cintex Services Llc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Cintex Svcs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05%
(reference standard) | gel | Prescription | TOPICAL | N/A | May 11, 2020 |
8. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | cream | Prescription | TOPICAL | AB | Dec 8, 2022 |
9. PAI HOLDINGS PHARM
Pai Holdings Llc Dba Pharmaceutical Associates Inc has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Pai Holdings Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Discontinued | TOPICAL | N/A | Mar 12, 2019 |
10. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | ointment | Prescription | TOPICAL | AB | Sep 15, 2017 |
11. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Desonide. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05% | lotion | Prescription | TOPICAL | AB | Sep 26, 2017 |
12. GALDERMA LABS LP
Galderma Laboratories Lp has filed for 1 generic for Desonide. This 0.05% version comes by the name DESOWEN. Given below are the details of the strengths of this generic introduced by Galderma Labs Lp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.05%
(reference standard) | lotion | Prescription | TOPICAL | AB | Jan 24, 1992 |